Is Roche Holding a buy?

Is Roche Holding a buy?

Roche Holding AG - Hold Valuation metrics show that Roche Holding AG may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of RHHBY, demonstrate its potential to outperform the market. It currently has a Growth Score of A.

Does Roche pay dividends?

4 Beginning in 2019, Roche Holding Ltd dividend to ADR holders will be paid in two stages....Timetable for payment of the 2020 dividend.

AGM / Declaration date1	Tuesday
Ex-dividend date2	Thursday
Record date3	Friday
Payment date4	Monday

Is Roche listed on the NYSE?

The underlying Roche Group security (Roche Holding AG) is listed on the SIX Swiss Exchange (Switzerland's principal stock exchange) under the stock symbols stock symbols RO. SW (voting share) and ROG. SW (non-voting equity security) and adheres to strict financial reporting standards and regulations.

Why is Roche an OTC stock?

Unlike most of the other OTC-listed names, however, that's not because it can't meet the NASDAQ's or NYSE's listing standards. It trades over the counter in the U.S. because it can be an enormous pain for a foreign stock (Roche is a Swiss company) to satisfy the United States' exchange-listing rules.

How do I invest in Roche?

How can I invest in Roche? For an investor in the United States, a position in Roche can be acquired through an American Depositary Receipt (ADR) traded on OTCQX International Premier under the symbol RHHBY.

What do analysts say about Roche?

The 20 analysts offering 12-month price forecasts for Roche Holding AG have a median target of 53.71, with a high estimate of 63.72 and a low estimate of 45.23. The median estimate represents a +3.37% increase from the last price of 51.96.

What is Roche famous for?

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.

What company owns Genentech?

Roche Holding AG Genentech/Organizzazioni principali Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years.

When did Roche go public?

F. Hoffmann-La Roche & Co. is founded in Basel, Switzerland. 1919: The company goes public.

What is ROG SW?

SW - Roche Holding AG. Swiss - Swiss Delayed Price. Currency in CHF.

What is the business model of Roche Holding AG?

• Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience.

What are Wall Street analysts' price targets for Roche's stock?

• 11 Wall Street analysts have issued 12-month price objectives for Roche's stock. Their forecasts range from $46.42 to $46.42. On average, they anticipate Roche's stock price to reach $46.42 in the next twelve months.

Is Roche (Roche) a good stock to buy?

• The company was founded by Fritz Hoffmann-La Roche on Octo and is headquartered in Basel, Switzerland. Roche has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 4 buy ratings, 6 hold ratings, and 1 sell rating.

What does Roche do for a living?

• About Roche Holding AG Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.